ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 120 filers reported holding ERASCA INC in Q4 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29,852 | +392.0% | 12,649 | +329.5% | 0.00% | – |
| Q1 2024 | $6,067 | -84.3% | 2,945 | -83.8% | 0.00% | – |
| Q4 2023 | $38,638 | +57.8% | 18,140 | +45.9% | 0.00% | -100.0% |
| Q3 2023 | $24,485 | +138.2% | 12,429 | +233.8% | 0.00% | – |
| Q2 2023 | $10,278 | +29265.7% | 3,724 | -67.7% | 0.00% | -100.0% |
| Q1 2023 | $35 | +775.0% | 11,526 | +1180.7% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 900 | -81.7% | 0.00% | -100.0% |
| Q3 2022 | $38,000 | +15.2% | 4,910 | -17.5% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -50.7% | 5,949 | -23.5% | 0.00% | 0.0% |
| Q1 2022 | $67,000 | +148.1% | 7,775 | +348.1% | 0.00% | – |
| Q4 2021 | $27,000 | +28.6% | 1,735 | +76.9% | 0.00% | -100.0% |
| Q3 2021 | $21,000 | – | 981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $95,078,000 | 13.59% |
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $21,500,000 | 12.39% |
| Cormorant Asset Management, LP | 10,505,554 | $90,348,000 | 6.94% |
| EDBI Pte Ltd | 888,888 | $7,644,000 | 5.09% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,688,000 | 1.94% |
| PFM Health Sciences, LP | 4,791,406 | $41,206,000 | 1.54% |
| Artal Group S.A. | 3,172,221 | $27,281,000 | 1.14% |
| AH Equity Partners V, L.L.C. | 50,000 | $430,000 | 1.02% |
| Orbimed Advisors | 1,667,693 | $14,342,000 | 0.23% |
| EcoR1 Capital, LLC | 678,441 | $5,835,000 | 0.18% |